CRISPR gene editing protects healthy cells in blood cancer trial
Genetically modifying donor stem cells with CRISPR technology before a transplant can remove the CD33 protein, successfully protecting healthy blood cells from follow-up immunotherapies and offering a safer path to treat aggressive blood cancers like acute myeloid leukemia, according to a clinical trial published in Nature Medicine. CRISPR Gene Editing Removes CD33 Protein to Protect … Read more